Yahoo
NasdaqGM - Nasdaq Real Time Price USD

STAAR Surgical Company (STAA)

23.39 -1.16 (-4.73%)
As of 10:51:35 AM EST. Market Open.
Trade STAA on Coinbase

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Warren Foust
CEO, President & Director 1.44M -- 1976
Ms. Deborah J. Andrews
Executive VP & CFO 1.18M -- 1957
Dr. Magda Michna Ph.D.
Chief Development Officer 895.72k -- --
Dr. Ben Park Ph.D.
Chief Technology Officer -- -- --
Ms. Connie Johnson
Director of Investor Relations -- -- --
Ms. Kathleen Determann J.D.
VP, Deputy General Counsel and Chief Compliance & Privacy Officer -- -- --
Mr. William W. Goodmen
Vice President of Global Human Resources -- -- 1955
Mr. David Bailey
Chief Commercial Officer 1.07M 409.18k 1957
Dr. Scott D. Barnes M.D.
Chief Medical Officer 691.15k -- 1963
Mr. Filip De Keersmaecker
Chief Supply Chain & Quality Officer -- -- --

STAAR Surgical Company

25510 Commercentre Drive
Lake Forest, CA 92630
United States
626 303 7902 https://www.staar.com
Sector: 
Healthcare
Full Time Employees: 
921

Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Corporate Governance

STAAR Surgical Company’s ISS Governance QualityScore as of November 1, 2026 is 6. The pillar scores are Audit: 5; Board: 3; Shareholder Rights: 7; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 4, 2026 at 9:00 PM UTC

STAAR Surgical Company Earnings Date

Recent Events

November 4, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 5, 2026 at 12:00 AM UTC

8-K/A: Corporate Changes & Voting Matters

September 10, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 12, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 6, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 24, 2026 at 12:00 AM UTC

S-8: Offering Registrations

June 22, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 9, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 13, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 4, 2026 at 12:00 AM UTC

ARS: Annual Report to Shareholders

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: